Expression and genomic profiling of colorectal cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1775, Issue 1, 2007, Pages 103-137

  Cardoso, J ^a,b   Boer, J ^b   Morreau, H ^c   Fodde, R ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b Medical Center   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adenoma; Array CGH; Carcinoma; Colorectal cancer; Expression profiling; Genomic profiling; Genomics; Metastasis

Indexed keywords

ADENOMA; ANALYTIC METHOD; BIOINFORMATICS; CANCER GROWTH; CANCER STAGING; CANCER STEM CELL; CARCINOGENESIS; CELL FUNCTION; CELL HETEROGENEITY; COHORT ANALYSIS; COLORECTAL CANCER; DIAGNOSTIC TEST; GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC ANALYSIS; GENETIC MARKER; GENETIC STABILITY; GENETIC VARIABILITY; HUMAN; INFORMATION PROCESSING; INTEGRATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCIENTIFIC LITERATURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADENOMA; CARCINOMA; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; INTESTINAL MUCOSA; NEOPLASM METASTASIS; PROGNOSIS;

EID: 33845336842     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2006.08.004     Document Type: Review

References (203)

1. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
2. Jemal A., Thomas A., Murray T., and Thun M. Cancer statistics. CA Cancer J. Clin. 52 (2002) 23-47
3. Tomatis L., and Bartsch H. The contribution of experimental studies to risk assessment of carcinogenic agents in humans. Exp. Pathol. 40 (1990) 251-266
4. WCRF and AICR Food, nutrition and prevention of cancer: a global perspective. In: AIoC Research (ed.). Washington: WCRF and AICR. World Cancer Research Fund and American Institute for Cancer Research, 1997.
5. Bingham S.A., Day N.E., Luben R., et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361 (2003) 1496-1501
6. Giovannucci E., and Martinez M.E. Tobacco, colorectal cancer, and adenomas: a review of the evidence. J. Natl. Cancer Inst. 88 (1996) 1717-1730
7. Labianca R., Beretta G., Gatta G., de Braud F., and Wils J. Colon cancer. Crit. Rev. Oncol./Hematol. 51 (2004) 145-170
8. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat. Rev., Cancer 4 (2004) 769-780
9. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
10. Rosenberg D.W., and Liu Y. Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis. Cancer Lett. 92 (1995) 209-214
11. Papanikolaou A., Wang Q.S., Delker D.A., and Rosenberg D.W. Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. Cancer Lett. 130 (1998) 29-34
12. Papanikolaou A., Wang Q.S., Papanikolaou D., Whiteley H.E., and Rosenberg D.W. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis 21 (2000) 1567-1572
13. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37 (1987) 147-151
14. Nucci M.R., Robinson C.R., Longo P., Campbell P., and Hamilton S.R. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum. Pathol. 28 (1997) 1396-1407
15. Smith A.J., Stern H.S., Penner M., et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res. 54 (1994) 5527-5530
16. Lamlum H., Papadopoulou A., Ilyas M., et al. APC mutations are sufficient for the growth of early colorectal adenomas. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2225-2228
17. Powell S.M., Zilz N., Beazer-Barclay Y., et al. APC mutations occur early during colorectal tumorigenesis. Nature 359 (1992) 235-237
18. Miyoshi Y., Nagase H., Ando H., et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet. 1 (1992) 229-233
19. Fodde R., Smits R., and Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev., Cancer 1 (2001) 55-67
20. Polakis P. The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev. 9 (1999) 15-21
21. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
22. Morin P.J., Sparks A.B., Korinek V., et al. Activation of beta-catenin- Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
23. Rubinfeld B., Albert I., Porfiri E., et al. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272 (1996) 1023-1026
24. Sparks A.B., Morin P.J., Vogelstein B., and Kinzler K.W. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58 (1998) 1130-1134
25. Ilyas M., Tomlinson I.P., Rowan A., Pignatelli M., and Bodmer W.F. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10330-10334
26. Lammi L., Arte S., Somer M., et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am. J. Hum. Genet. 74 (2004) 1043-1050
27. Bos J.L., Fearon E.R., Hamilton S.R., et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 327 (1987) 293-297
28. Andreyev H.J., Norman A.R., Cunningham D., et al. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br. J. Cancer 85 (2001) 692-696
29. Forrester K., Almoguera C., Han K., Grizzle W.E., and Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327 (1987) 298-303
30. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319 (1988) 525-532
31. Rajagopalan H., Bardelli A., Lengauer C., et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418 (2002) 934
32. Davies H., Bignell G.R., Cox C., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
33. Takayama T., Ohi M., Hayashi T., et al. Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121 (2001) 599-611
34. Markowitz S., Wang J., Myeroff L., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268 (1995) 1336-1338
35. Takagi Y., Kohmura H., Futamura M., et al. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111 (1996) 1369-1372
36. Eppert K., Scherer S.W., Ozcelik H., et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86 (1996) 543-552
37. Thiagalingam S., Lengauer C., Leach F.S., et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet. 13 (1996) 343-346
38. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
39. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342 (2000) 1350-1358
40. Purdie C.A., O'Grady J., Piris J., Wyllie A.H., and Bird C.C. p53 expression in colorectal tumors. Am. J. Pathol. 138 (1991) 807-813
41. Delattre O., Olschwang S., Law D.J., et al. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet 2 (1989) 353-356
42. Baker S.J., Fearon E.R., Nigro J.M., et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244 (1989) 217-221
43. Iacopetta B. TP53 mutation in colorectal cancer. Hum. Mutat. 21 (2003) 271-276
44. Wang Z., Cummins J.M., Shen D., et al. Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res. 64 (2004) 2998-3001
45. Samuels Y., Wang Z., Bardelli A., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
46. Bardelli A., Parsons D.W., Silliman N., et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300 (2003) 949
47. Parsons D.W., Wang T.L., Samuels Y., et al. Colorectal cancer: mutations in a signalling pathway. Nature 436 (2005) 792
48. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
49. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., and Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363 (1993) 558-561
50. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon [see comments]. Science 260 (1993) 816-819
51. Muleris M., Salmon R.J., and Dutrillaux B. Cytogenetics of colorectal adenocarcinomas. Cancer Genet. Cytogenet. 46 (1990) 143-156
52. Bardi G., Sukhikh T., Pandis N., et al. Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer 12 (1995) 97-109
53. Thiagalingam S., Laken S., Willson J.K., et al. Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2698-2702
54. Bhattacharyya N.P., Skandalis A., Ganesh A., Groden J., and Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 6319-6323
55. Parsons R., Li G.M., Longley M.J., et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 75 (1993) 1227-1236
56. Eshleman J.R., Casey G., Kochera M.E., et al. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53. Oncogene 17 (1998) 719-725
57. Chan T.L., Curtis L.C., Leung S.Y., et al. Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes. Oncogene 20 (2001) 4871-4876
58. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J. Clin. Oncol. 21 (2003) 1174-1179
59. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev., Genet. 3 (2002) 415-428
60. Pihan G., and Doxsey S.J. Mutations and aneuploidy: co-conspirators in cancer?. Cancer Cell 4 (2003) 89-94
61. Cahill D.P., Lengauer C., Yu J., et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998) 300-303
62. Shichiri M., Yoshinaga K., Hisatomi H., Sugihara K., and Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 62 (2002) 13-17
63. Rajagopalan H., Jallepalli P.V., Rago C., et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 428 (2004) 77-81
64. Fukasawa K., Choi T., Kuriyama R., Rulong S., and Vande Woude G.F. Abnormal centrosome amplification in the absence of p53. Science 271 (1996) 1744-1747
65. Bardi G., Parada L.A., Bomme L., et al. Cytogenetic comparisons of synchronous carcinomas and polyps in patients with colorectal cancer. Br. J. Cancer 76 (1997) 765-769
66. Giaretti W. A model of DNA aneuploidization and evolution in colorectal cancer. Lab. Invest. 71 (1994) 904-910
67. Shih I.M., Zhou W., Goodman S.N., et al. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res. 61 (2001) 818-822
68. Kaplan K.B., Burds A.A., Swedlow J.R., et al. A role for the adenomatous polyposis coli protein in chromosome segregation. Nat. Cell Biol. 3 (2001) 429-432
69. Fodde R., Kuipers J., Rosenberg C., et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat. Cell Biol. 3 (2001) 433-438
70. Cahill D.P., Kinzler K.W., Vogelstein B., and Lengauer C. Genetic instability and darwinian selection in tumours. Trends Cell Biol. 9 (1999) M57-M60
71. Bernards R., and Weinberg R.A. A progression puzzle. Nature 418 (2002) 823
72. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 10869-10874
73. van 't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
74. Minn A.J., Gupta G.P., Siegel P.M., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
75. Liefers G.J., and Tollenaar R.A. Cancer genetics and their application to individualised medicine. Eur. J. Cancer 38 (2002) 872-879
76. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
77. DeRisi J., Penland L., Brown P.O., et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14 (1996) 457-460
78. Lipshutz R.J., Morris D., Chee M., et al. Using oligonucleotide probe arrays to access genetic diversity. Biotechniques 19 (1995) 442-447
79. Snijders A.M., Nowak N., Segraves R., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29 (2001) 263-264
80. Augenlicht L.H., Wahrman M.Z., Halsey H., et al. Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro. Cancer Res. 47 (1987) 6017-6021
81. Augenlicht L.H., Taylor J., Anderson L., and Lipkin M. Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3286-3289
82. Alon U., Barkai N., Notterman D.A., et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 6745-6750
83. Notterman D.A., Alon U., Sierk A.J., and Levine A.J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 61 (2001) 3124-3130
84. Kitahara O., Furukawa Y., Tanaka T., et al. Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res. 61 (2001) 3544-3549
85. Takemasa I., Higuchi H., Yamamoto H., et al. Construction of preferential cDNA microarray specialized for human colorectal carcinoma: molecular sketch of colorectal cancer. Biochem. Biophys. Res. Commun. 285 (2001) 1244-1249
86. Birkenkamp-Demtroder K., Christensen L.L., Olesen S.H., et al. Gene expression in colorectal cancer. Cancer Res. 62 (2002) 4352-4363
87. Zou T.T., Selaru F.M., Xu Y., et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 21 (2002) 4855-4862
88. Ichikawa Y., Ishikawa T., Takahashi S., et al. Identification of genes regulating colorectal carcinogenesis by using the algorithm for diagnosing malignant state method. Biochem. Biophys. Res. Commun. 296 (2002) 497-506
89. Frederiksen C.M., Knudsen S., Laurberg S., and Orntoft T.F. Classification of Dukes' B and C colorectal cancers using expression arrays. J. Cancer Res. Clin. Oncol. 129 (2003) 263-271
90. Muro S., Takemasa I., Oba S., et al. Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data. Genome Biol. 4 (2003) R21
91. Bertucci F., Salas S., Eysteries S., et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23 (2004) 1377-1391
92. Koehler A., Bataille F., Schmid C., et al. Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J. Pathol. 204 (2004) 65-74
93. Kwon H.C., Kim S.H., Roh M.S., et al. Gene expression profiling in lymph node-positive and lymph node-negative colorectal cancer. Dis. Colon. Rectum. 47 (2004) 141-152
94. Li M., Lin Y.M., Hasegawa S., et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int. J. Oncol. 24 (2004) 305-312
95. Komori T., Takemasa I., Higuchi H., et al. Identification of differentially expressed genes involved in colorectal carcinogenesis using a cDNA microarray. J. Exp. Clin. Cancer Res. 23 (2004) 521-527
96. Croner R.S., Peters A., Brueckl W.M., et al. Microarray versus conventional prediction of lymph node metastasis in colorectal carcinoma. Cancer 104 (2005) 395-404
97. Barrier A., Lemoine A., Boelle P.Y., et al. Colon cancer prognosis prediction by gene expression profiling. Oncogene (2005)
98. D'Arrigo A., Belluco C., Ambrosi A., et al. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int. J. Cancer (2005)
99. Birkenkamp-Demtroder K., Olesen S.H., Sorensen F.B., et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 54 (2005) 374-384
100. Komuro K., Tada M., Tamoto E., et al. Right- and left-sided colorectal cancers display distinct expression profiles and the anatomical stratification allows a high accuracy prediction of lymph node metastasis. J. Surg. Res. 124 (2005) 216-224
101. Hegde P., Qi R., Gaspard R., et al. Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res. 61 (2001) 7792-7797
102. Lin Y.M., Furukawa Y., Tsunoda T., et al. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21 (2002) 4120-4128
103. Lechner S., Muller-Ladner U., Renke B., et al. Gene expression pattern of laser microdissected colonic crypts of adenomas with low grade dysplasia. Gut 52 (2003) 1148-1153
104. Nosho K., Yamamoto H., Adachi Y., et al. Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. Br. J. Cancer 92 (2005) 1193-1200
105. Williams N.S., Gaynor R.B., Scoggin S., et al. Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin. Cancer Res. 9 (2003) 931-946
106. Banerjea A., Ahmed S., Hands R.E., et al. Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol. Cancer 3 (2004) 21
107. Kim H., Nam S.W., Rhee H., et al. Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas. Oncogene 23 (2004) 6218-6225
108. Kruhoffer M., Jensen J.L., Laiho P., et al. Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br. J. Cancer 92 (2005) 2240-2248
109. Agrawal D., Chen T., Irby R., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J. Natl. Cancer Inst. 94 (2002) 513-521
110. Tsunoda T., Nakamura T., Ishimoto K., et al. Upregulated expression of angiogenesis genes and down regulation of cell cycle genes in human colorectal cancer tissue determined by cDNA macroarray. Anticancer Res. 21 (2001) 137-143
111. Scherl-Mostageer M., Sommergruber W., Abseher R., et al. Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer. Oncogene 20 (2001) 4402-4408
112. Wang Y., Jatkoe T., Zhang Y., et al. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. J. Clin. Oncol. 22 (2004) 1564-1571
113. Wielenga V.J., Smits R., Korinek V., et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am. J. Pathol. 154 (1999) 515-523
114. Warburg O. On respiratory impairment in cancer cells. Science 124 (1956) 269-270
115. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J. Clin. Oncol. 17 (1999) 1356-1363
116. Mamounas E., Wieand S., Wolmark N., et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04). J. Clin. Oncol. 17 (1999) 1349-1355
117. Moertel C.G., Fleming T.R., Macdonald J.S., et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N. Engl. J. Med. 322 (1990) 352-358
118. Moertel C.G., Fleming T.R., Macdonald J.S., et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann. Intern. Med. 122 (1995) 321-326
119. Augenlicht L.H., and Heerdt B.G. Mitochondria: integrators in tumorigenesis?. Nat. Genet. 28 (2001) 104-105
120. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5116-5121
121. Arango D., Laiho P., Kokko A., et al. Gene-expression profiling predicts recurrence in dukes' C colorectal cancer. Gastroenterology 129 (2005) 874-884
122. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58 (1998) 5248-5257
123. Dunican D.S., McWilliam P., Tighe O., arle-McDermott PA., and Croke D.T. Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization. Oncogene 21 (2002) 3253-3257
124. Yuan Sotsky Z., Kent T., and Weber T.K. Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer. Oncogene 22 (2003) 6304-6310
125. Mori Y., Selaru F.M., Sato F., et al. The impact of microsatellite instability on the molecular phenotype of colorectal tumors. Cancer Res. 63 (2003) 4577-4582
126. Raychaudhuri S., Stuart J.M., and Altman R.B. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac. Symp. Biocomput. (2000) 455-466
127. Tomlinson I., Halford S., Aaltonen L., Hawkins N., and Ward R. Does MSI-low exist?. J. Pathol. 197 (2002) 6-13
128. Halford S., Sasieni P., Rowan A., et al. Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res. 62 (2002) 53-57
129. Biemer-Huttmann A.E., Walsh M.D., McGuckin M.A., et al. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin. Cancer Res. 6 (2000) 1909-1916
130. Whitehall V.L., Walsh M.D., Young J., Leggett B.A., and Jass J.R. Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res. 61 (2001) 827-830
131. Dolcetti R., Viel A., Doglioni C., et al. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am. J. Pathol. 154 (1999) 1805-1813
132. Guidoboni M., Gafa R., Viel A., et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am. J. Pathol. 159 (2001) 297-304
133. Duval A., and Hamelin R. Genetic instability in human mismatch repair deficient cancers. Ann. Genet. 45 (2002) 71-75
134. Giacomini C.P., Leung S.Y., Chen X., et al. A gene expression signature of genetic instability in colon cancer. Cancer Res. 65 (2005) 9200-9205
135. di Pietro M., Bellver J.S., Menigatti M., et al. Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology 129 (2005) 1047-1059
136. Glebov O.K., Rodriguez L.M., Nakahara K., et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol., Biomarkers Prev. 12 (2003) 755-762
137. Brabletz T., Jung A., Dag S., Hlubek F., and Kirchner T. betacatenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155 (1999) 1033-1038
138. Habets G.G., van der Kammen R.A., Willemsen V., et al. Sublocalization of an invasion-inducing locus and other genes on human chromosome 7. Cytogenet. Cell Genet. 60 (1992) 200-205
139. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R.A. molecular signature of metastasis in primary solid tumors. Nat. Genet. 33 (2003) 49-54
140. Weigelt B., Glas A.M., Wessels L.F., et al. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15901-15905
141. Brabletz T., Jung A., Spaderna S., Hlubek F., and Kirchner T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat. Rev., Cancer 5 (2005) 744-749
142. Otsuka M., Kato M., Yoshikawa T., et al. Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem. Biophys. Res. Commun. 289 (2001) 876-881
143. Mariadason J.M., Arango D., and Augenlicht L.H. Customizing chemotherapy for colon cancer: the potential of gene expression profiling. Drug Resist. Updat. 7 (2004) 209-218
144. Mariadason J.M., Arango D., Shi Q., et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res. 63 (2003) 8791-8812
145. Arango D., Wilson A.J., Shi Q., et al. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br. J. Cancer 91 (2004) 1931-1946
146. Shimizu D., Ishikawa T., Ichikawa Y., et al. Prediction of chemosensitivity of colorectal cancer to 5-fluorouracil by gene expression profiling with cDNA microarrays. Int. J. Oncol. 27 (2005) 371-376
147. Inoue Y., Tanaka K., Hiro J., et al. in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer. Int. J. Oncol. 28 (2006) 479-486
148. Scherf U., Ross D.T., Waltham M., et al. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24 (2000) 236-244
149. Dan S., Tsunoda T., Kitahara O., et al. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res. 62 (2002) 1139-1147
150. Zembutsu H., Ohnishi Y., Tsunoda T., et al. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res. 62 (2002) 518-527
151. Wang W., Marsh S., Cassidy J., and McLeod H.L. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors. Cancer Res. 61 (2001) 5505-5510
152. Schmidt W.M., Kalipciyan M., Dornstauder E., et al. Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int. J. Cancer 112 (2004) 200-212
153. Clarke P.A., George M.L., Easdale S., et al. Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profiling. Cancer Res. 63 (2003) 6855-6863
154. Inoue Y., Shirane M., Miki C., et al. Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapy. Int. J. Oncol. 25 (2004) 1641-1649
155. Ghadimi B.M., Grade M., Difilippantonio M.J., et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J. Clin. Oncol. 23 (2005) 1826-1838
156. Solinas-Toldo S., Lampel S., Stilgenbauer S., et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20 (1997) 399-407
157. Pinkel D., Segraves R., Sudar D., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20 (1998) 207-211
158. Albertson D.G., Ylstra B., Segraves R., et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25 (2000) 144-146
159. Bentz M., Plesch A., Stilgenbauer S., Dohner H., and Lichter P. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 21 (1998) 172-175
160. Kallioniemi O.P., Kallioniemi A., Piper J., et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10 (1994) 231-243
161. Kirchhoff M., Gerdes T., Rose H., et al. Detection of chromosomal gains and losses in comparative genomic hybridization analysis based on standard reference intervals. Cytometry 31 (1998) 163-173
162. Pollack J.R., Perou C.M., Alizadeh A.A., et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23 (1999) 41-46
163. Zhou X., Rao N.P., Cole S.W., et al. Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. Cancer Genet. Cytogenet. 159 (2005) 53-57
164. Cardoso J., Molenaar L., de Menezes R.X., et al. Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH. Nucleic Acids Res. 32 (2004) e146
165. Richter H., Slezak P., Walch A., et al. Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. Am. J. Pathol. 163 (2003) 287-294
166. Diep C.B., Kleivi K., Ribeiro F.R., et al. The order of genetic events associated with colorectal cancer progression inferred from meta76 analysis of copy number changes. Genes Chromosomes Cancer 45 (2006) 31-41
167. Nakao K., Mehta K.R., Fridlyand J., et al. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25 (2004) 1345-1357
168. Douglas E.J., Fiegler H., Rowan A., et al. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res. 64 (2004) 4817-4825
169. Jones A.M., Douglas E.J., Halford S.E., et al. Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 24 (2005) 118-129
170. Camps J., Armengol G., Del Rey J., et al. Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis (2005)
171. Cardoso J., Molenaar L., de Menezes R.X., et al. Chromosomal instability in MYH- and APC-mutant adenomatous polyps. Cancer Res. 66 (2006) 2514-2519
172. Davison E.J., Tarpey P.S., Fiegler H., Tomlinson I.P., and Carter N.P. Deletion at chromosome band 20p12.1 in colorectal cancer revealed by high resolution array comparative genomic hybridization. Genes Chromosomes Cancer 44 (2005) 384-391
173. Westbrook T.F., Martin E.S., Schlabach M.R., et al. A genetic screen for candidate tumor suppressors identifies REST. Cell 121 (2005) 837-848
174. Mehta K.R., Nakao K., Zuraek M.B., et al. Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer. Clin. Cancer Res. 11 (2005) 1791-1797
175. Tanami H., Tsuda H., Okabe S., et al. Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis. Lab. Invest. 85 (2005) 1118-1129
176. Buffart T.E., Coffa J., Hermsen M.A., et al. DNA copy number changes at 8q11-24 in metastasized colorectal cancer. Cell Oncol. 27 (2005) 57-65
177. Shih W., Chetty R., and Tsao M.S. Expression profiling by microarrays in colorectal cancer (Review). Oncol. Rep. 13 (2005) 517-524
178. Gillespie J.W., Ahram M., Best C.J., et al. The role of tissue microdissection in cancer research. Cancer J. 7 (2001) 32-39
179. Stuart R.O., Wachsman W., Berry C.C., et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 615-620
180. Ma X.J., Salunga R., Tuggle J.T., et al. Gene expression profiles of human breast cancer progression. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 5974-5979
181. Crnogorac-Jurcevic T., Efthimiou E., Nielsen T., et al. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21 (2002) 4587-4594
182. Perou C.M., Jeffrey S.S., van de Rijn M., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9212-9217
183. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
184. St Croix B., Rago C., Velculescu V., et al. Genes expressed in human tumor endothelium. Science 289 (2000) 1197-1202
185. Selaru F.M., Xu Y., Yin J., et al. Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology 122 (2002) 606-613
186. Mori Y., Yin J., Sato F., et al. Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning. Cancer Res. 64 (2004) 2434-2438
187. Ransohoff D.F. Rules of evidence for cancer molecular-marker discovery and validation. Nat. Rev., Cancer 4 (2004) 309-314
188. Aguirre A.J., Brennan C., Bailey G., et al. High-resolution characterization of the pancreatic adenocarcinoma genome. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9067-9072
189. Pollack J.R., Sorlie T., Perou C.M., et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12963-12968
190. Platzer P., Upender M.B., Wilson K., et al. Silence of chromosomal amplifications in colon cancer. Cancer Res. 62 (2002) 1134-1138
191. Graeber T.G., and Sawyers C.L. Cross-species comparisons of cancer signaling. Nat. Genet. 37 (2005) 7-8
192. Paoni N.F., Feldman M.W., Gutierrez L.S., Ploplis V.A., and Castellino F.J. Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse. Physiol. Genomics 15 (2003) 228-235
193. Leclerc D., Deng L., Trasler J., and Rozen R. ApcMin/+ mouse model of colon cancer: gene expression profiling in tumors. J. Cell. Biochem. 93 (2004) 1242-1254
194. Reichling T., Goss K.H., Carson D.J., et al. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res. 65 (2005) 166-176
195. Martinez C., Bhattacharya S., Freeman T., Churchman M., and Ilyas M. Expression profiling of murine intestinal adenomas reveals early deregulation of multiple matrix metalloproteinase (Mmp) genes. J. Pathol. 206 (2005) 100-110
196. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347 (2002) 1999-2009
197. Wang Y., Klijn J.G., Zhang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
198. Ein-Dor L., Kela I., Getz G., Givol D., and Domany E. Outcome signature genes in breast cancer: is there a unique set?. Bioinformatics 21 (2005) 171-178
199. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
200. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
201. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3983-3988
202. Singh S.K., Clarke I.D., Hide T., and Dirks P.B. Cancer stem cells in nervous system tumors. Oncogene 23 (2004) 7267-7273
203. Pinheiro N.A., Caballero O.L., Soares F., Reis L.F., and Simpson A.J. Significant overexpression of oligophrenin-1 in colorectal tumors detected by cDNA microarray analysis. Cancer Lett. 172 (2001) 67-73